長讀長定序市場規模、佔有率和成長分析（按產品、技術、工作流程、應用、用途、最終用戶和地區分類）－2026-2033年產業預測

預計到 2024 年，全球長讀定序市場規模將達到 7.7992 億美元，從 2025 年的 10.2092 億美元成長到 2033 年的 88.049 億美元，在預測期（2026-2033 年）內複合年成長率為 30.9%。

全球長讀長定定序(LRS) 市場的發展主要受遺傳疾病發生率上升、個人化醫療需求成長以及第三代定序等技術進步的推動。尤其值得一提的是，全球健康危機促使人們對創新定序技術的需求激增，因為效用。 LRS，包括單分子即時定序 (SMRT) 和奈米孔定序等技術，具有許多顯著優勢，例如能夠檢測傳統定序難以識別的複雜基因組特徵，以及實現精準的基因組組裝。憑藉其分析複雜基因區域和染色體異常的強大能力，LRS 已成為臨床研究的關鍵工具。同時，產業領導者對先進基因組技術的大規模投資預計將進一步推動市場成長。

全球長讀長定序市場促進因素

全球長讀長定序市場的發展主要得益於次世代定序（NGS）技術在基因體學、轉錄組學和表觀基因等多個研究領域的廣泛應用。長讀長定序能夠顯著提升對基因組組裝、基因表現和DNA修飾模式的理解，這極大地促進了其在以NGS為核心的研究舉措中的日益普及和整合。研究人員越來越依賴這項技術來獲取更深入的見解和更全面的數據，從而推動各個科學領域的創新和進步，並促進其在全球研究界的廣泛應用。

壓制全球長讀長定序市場

全球長讀長定序市場面臨挑戰，因為與傳統的短讀長定序方法相比，這些技術的成本相對較高。這種經濟負擔主要源自於專用設備、試劑和全面數據分析的成本，而這些成本可能相當可觀。這個經濟因素可能會阻礙長讀長定定序在各種環境中的廣泛應用，尤其是在資源有限的臨床診斷和研究實驗室。因此，成本方面的考慮可能會限制這些先進定序解決方案在更常規的應用和環境中的整合。

全球長讀長定序市場趨勢

隨著研究人員和醫療專業人員日益認知到長讀長定序技術在提供詳細、精確的基因組分析方面的優勢，全球長讀長定序市場正經歷強勁成長。這一轉變是由基因組組裝、結構變異分析和轉錄組學等多個應用領域需求的激增所驅動。隨著傳統短讀長定定序的限制日益凸顯，人們對能夠分析複雜遺傳環境的創新解決方案的興趣也日益濃厚。預計長讀長定序技術的持續進步將進一步推動其應用，增強科研能力，並促進個人化醫療的發展。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術進步
• 監管環境

全球長讀長定序市場規模（依產品類型及複合年成長率分類）（2026-2033 年）

• 消耗品
• 裝置
• 服務

全球長讀長定序市場規模（依技術分類）及複合年成長率（2026-2033 年）

• 奈米孔定序
• 單分子即時定序
• 合成長讀定序

全球長讀長定序市場規模（依工作流程及複合年成長率分類）（2026-2033 年）

• 定序
• 樣品製備
• 數據分析

全球長讀長定序市場規模（依應用及複合年成長率分類）（2026-2033 年）

• 全基因組定序
• 標靶定序
• 總體基因體學
• 表觀遺傳學
• 全外EXOME定序
• 其他用途

全球長讀長定序市場規模（按用途和複合年成長率分類）（2026-2033 年）

• 研究
• 臨床

全球長讀長定序市場規模（以最終用戶分類）及複合年成長率（2026-2033 年）

• 學術和研究機構
• 醫院、診所和診斷檢查室
• 製藥和生物技術公司
• 其他最終用戶

全球長讀長定序市場規模（按地區分類）及複合年成長率（2026-2033 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Pacific Biosciences of California, Inc.（PacBio）（United States）
• Oxford Nanopore Technologies plc（United Kingdom）
• Illumina, Inc.（United States）
• BGI Genomics Co., Ltd.（China）
• 10x Genomics, Inc.（United States）
• Agilent Technologies, Inc.（United States）
• Thermo Fisher Scientific Inc.（United States）
• QIAGEN NV（Germany）
• Takara Bio Inc.（Japan）
• Danaher Corporation（United States）
• Novogene Co., Ltd.（China）
• New England Biolabs, Inc.（United States）
• Element Biosciences, Inc.（United States）
• Revvity, Inc.（United States）
• Eurofins Scientific SE（Luxembourg）
• Bio-Rad Laboratories, Inc.（United States）
• PerkinElmer, Inc.（United States）
• Roche Holding AG（Switzerland）
• Merck KGaA（Germany）
• Bio-Techne Corporation（United States）

結論與建議

Global Long Read Sequencing Market size was valued at USD 779.92 Million in 2024 and is poised to grow from USD 1020.92 Million in 2025 to USD 8800.49 Million by 2033, growing at a CAGR of 30.9% during the forecast period (2026-2033).

The global market for long read sequencing (LRS) is being driven by the rising incidence of genetic disorders, the increasing appeal of personalized medicine, and significant technological advancements like third-generation sequencing. The demand for innovative sequencing techniques has surged due to their utility in diagnostics and drug development, particularly influenced by the global health crisis. LRS, including methods like Single Molecule Real Time (SMRT) and Nanopore sequencing, offers distinct advantages such as accurate genome assembly and the detection of complex genomic features that traditional sequencing struggles to identify. Enhanced capability to analyze challenging genetic regions and chromosomal abnormalities positions LRS as a pivotal tool in clinical research, while major investments in advanced genomic technologies from industry leaders promise to further accelerate market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Long Read Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Long Read Sequencing Market Segments Analysis

Global Long Read Sequencing Market is segmented by Offerings, Technology, Workflow, Application, Usage, End Users and region. Based on Offerings, the market is segmented into Consumables, Instruments and Services. Based on Technology, the market is segmented into Nanopore sequencing, Single-molecule real-time sequencing and Synthetic long-read sequencing. Based on Workflow, the market is segmented into Sequencing, Sample Preparation and Data analysis. Based on Application, the market is segmented into Whole Genome Sequencing, Targeted Sequencing, Metagenomics, Epigenetics, Whole exome sequencing and Other applications. Based on Usage, the market is segmented into Research and Clinical. Based on End Users, the market is segmented into Academic & Research Institutes, Hospitals, Clinics & Diagnostic Labs, Pharmaceutical & Biotechnology Companies and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Long Read Sequencing Market

The global market for Long Read Sequencing is significantly propelled by the widespread utilization of next-generation sequencing (NGS) technologies in diverse research domains such as genomics, transcriptomics, and epigenomics. The ability of long read sequencing to enhance our understanding of genome assembly, gene expression, and DNA modification patterns contributes greatly to its growing acceptance and integration into NGS-focused research initiatives. Researchers increasingly rely on this technology for its ability to provide deeper insights and more comprehensive data, thereby fostering innovation and advancements in various scientific disciplines and promoting its extensive adoption within the global research community.

Restraints in the Global Long Read Sequencing Market

The global long read sequencing market faces challenges due to the comparatively higher expenses associated with these technologies when measured against traditional short read sequencing methods. The financial burden stems from the costs of specialized instruments, reagents, and comprehensive data analysis, which can be substantial. This economic factor can hinder the widespread adoption of long read sequencing in various environments, particularly in clinical diagnostics and research facilities that may have limited resources. As a result, cost considerations may restrict the integration of these advanced sequencing solutions into more routine applications and settings.

Market Trends of the Global Long Read Sequencing Market

The Global Long Read Sequencing market is experiencing robust growth as researchers and healthcare professionals increasingly recognize the superiority of long read technologies for delivering detailed and precise genomic insights. This shift is fueled by a burgeoning demand across diverse applications, including genome assembly, structural variant analysis, and transcriptomics. As the limitations of traditional short read sequencing become more apparent, the industry is witnessing a heightened emphasis on innovative solutions that can navigate complex genetic landscapes. The ongoing advancements in long read sequencing technologies are poised to further catalyze their adoption, enhancing research capabilities and driving personalized medicine forward.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape

Global Long Read Sequencing Market Size by Offerings & CAGR (2026-2033)

• Market Overview
• Consumables
• Instruments
• Services

Global Long Read Sequencing Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Nanopore sequencing
• Single-molecule real-time sequencing
• Synthetic long-read sequencing

Global Long Read Sequencing Market Size by Workflow & CAGR (2026-2033)

• Market Overview
• Sequencing
• Sample Preparation
• Data analysis

Global Long Read Sequencing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Whole Genome Sequencing
• Targeted Sequencing
• Metagenomics
• Epigenetics
• Whole exome sequencing
• Other applications

Global Long Read Sequencing Market Size by Usage & CAGR (2026-2033)

• Market Overview
• Research
• Clinical

Global Long Read Sequencing Market Size by End Users & CAGR (2026-2033)

• Market Overview
• Academic & Research Institutes
• Hospitals, Clinics & Diagnostic Labs
• Pharmaceutical & Biotechnology Companies
• Other End Users

Global Long Read Sequencing Market Size & CAGR (2026-2033)

• North America (Offerings, Technology, Workflow, Application, Usage, End Users)
  • US
  • Canada
• Europe (Offerings, Technology, Workflow, Application, Usage, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Offerings, Technology, Workflow, Application, Usage, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Offerings, Technology, Workflow, Application, Usage, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Offerings, Technology, Workflow, Application, Usage, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Pacific Biosciences of California, Inc. (PacBio) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novogene Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Element Biosciences, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations